Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

832 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.
Then Bergh F, Kümpfel T, Schumann E, Held U, Schwan M, Blazevic M, Wismüller A, Holsboer F, Yassouridis A, Uhr M, Weber F, Daumer M, Trenkwalder C, Auer DP. Then Bergh F, et al. Among authors: holsboer f. BMC Neurol. 2006 May 23;6:19. doi: 10.1186/1471-2377-6-19. BMC Neurol. 2006. PMID: 16719908 Free PMC article. Clinical Trial.
Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized, double blind trial.
Then Bergh F, Kümpfel T, Grasser A, Rupprecht R, Holsboer F, Trenkwalder C. Then Bergh F, et al. Among authors: holsboer f. J Clin Endocrinol Metab. 2001 Apr;86(4):1610-5. doi: 10.1210/jcem.86.4.7416. J Clin Endocrinol Metab. 2001. PMID: 11297592 Clinical Trial.
832 results